Florida’s Senator Evers introduces a second bill to ban kratom.

 Florida Senate - 2015                                     SB 764
       
       
        
       By Senator Evers
       
       
       
       
       
       2-00616-15                                             2015764__
    1                        A bill to be entitled                      
    2         An act relating to controlled substances; amending s.
    3         893.03, F.S.; including kratom in a schedule of
    4         controlled substances; reenacting ss. 39.01(30)(a) and
    5         (g), 316.193(5), 322.2616(2)(c), 327.35(5),
    6         440.102(11)(b), 458.3265(1)(e), 459.0137(1)(e),
    7         782.04(1)(a) and (4), 787.06(2)(a), 817.563,
    8         831.31(1)(a) and (2), 856.015(1)(c), 893.02(4),
    9         893.035(2), (7)(a), and (8)(a), 893.0356(2)(a) and
   10         (5), 893.05(1), 893.12(2)(b), (c), and (d),
   11         893.13(1)(a), (c) through (f), and (h), (2)(a),
   12         (4)(b), (5)(b), and (7)(a), 921.0022(3)(b), (c), and
   13         (e), F.S., to incorporate the amendment made to s.
   14         893.03, F.S., in references thereto; providing an
   15         effective date.
   16          
   17  Be It Enacted by the Legislature of the State of Florida:
   18  
   19         Section 1. Paragraph (c) of subsection (1) of section
   20  893.03, Florida Statutes, is amended to read:
   21         893.03 Standards and schedules.—The substances enumerated
   22  in this section are controlled by this chapter. The controlled
   23  substances listed or to be listed in Schedules I, II, III, IV,
   24  and V are included by whatever official, common, usual,
   25  chemical, or trade name designated. The provisions of this
   26  section shall not be construed to include within any of the
   27  schedules contained in this section any excluded drugs listed
   28  within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
   29  Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
   30  Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
   31  Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
   32  Anabolic Steroid Products.”
   33         (1) SCHEDULE I.—A substance in Schedule I has a high
   34  potential for abuse and has no currently accepted medical use in
   35  treatment in the United States and in its use under medical
   36  supervision does not meet accepted safety standards. The
   37  following substances are controlled in Schedule I:
   38         (c) Unless specifically excepted or unless listed in
   39  another schedule, any material, compound, mixture, or
   40  preparation that contains any quantity of the following
   41  hallucinogenic substances or that contains any of their salts,
   42  isomers, including optical, positional, or geometric isomers,
   43  and salts of isomers, if the existence of such salts, isomers,
   44  and salts of isomers is possible within the specific chemical
   45  designation:
   46         1. Alpha-ethyltryptamine.
   47         2. 2-Amino-4-methyl-5-phenyl-2-oxazoline (4
   48  methylaminorex).
   49         3. 2-Amino-5-phenyl-2-oxazoline (Aminorex).
   50         4. 4-Bromo-2,5-dimethoxyamphetamine.
   51         5. 4-Bromo-2,5-dimethoxyphenethylamine.
   52         6. Bufotenine.
   53         7. Cannabis.
   54         8. Cathinone.
   55         9. Diethyltryptamine.
   56         10. 2,5-Dimethoxyamphetamine.
   57         11. 2,5-Dimethoxy-4-ethylamphetamine (DOET).
   58         12. Dimethyltryptamine.
   59         13. N-Ethyl-1-phenylcyclohexylamine (PCE) (Ethylamine
   60  analog of phencyclidine).
   61         14. N-Ethyl-3-piperidyl benzilate.
   62         15. N-ethylamphetamine.
   63         16. Fenethylline.
   64         17. N-Hydroxy-3,4-methylenedioxyamphetamine.
   65         18. Ibogaine.
   66         19. Lysergic acid diethylamide (LSD).
   67         20. Mescaline.
   68         21. Methcathinone.
   69         22. 5-Methoxy-3,4-methylenedioxyamphetamine.
   70         23. 4-methoxyamphetamine.
   71         24. 4-methoxymethamphetamine.
   72         25. 4-Methyl-2,5-dimethoxyamphetamine.
   73         26. 3,4-Methylenedioxy-N-ethylamphetamine.
   74         27. 3,4-Methylenedioxyamphetamine.
   75         28. N-Methyl-3-piperidyl benzilate.
   76         29. N,N-dimethylamphetamine.
   77         30. Parahexyl.
   78         31. Peyote.
   79         32. N-(1-Phenylcyclohexyl)-pyrrolidine (PCPY) (Pyrrolidine
   80  analog of phencyclidine).
   81         33. Psilocybin.
   82         34. Psilocyn.
   83         35. Salvia divinorum, except for any drug product approved
   84  by the United States Food and Drug Administration which contains
   85  Salvia divinorum or its isomers, esters, ethers, salts, and
   86  salts of isomers, esters, and ethers, if the existence of such
   87  isomers, esters, ethers, and salts is possible within the
   88  specific chemical designation.
   89         36. Salvinorin A, except for any drug product approved by
   90  the United States Food and Drug Administration which contains
   91  Salvinorin A or its isomers, esters, ethers, salts, and salts of
   92  isomers, esters, and ethers, if the existence of such isomers,
   93  esters, ethers, and salts is possible within the specific
   94  chemical designation.
   95         37. Tetrahydrocannabinols.
   96         38. 1-[1-(2-Thienyl)-cyclohexyl]-piperidine (TCP)
   97  (Thiophene analog of phencyclidine).
   98         39. 3,4,5-Trimethoxyamphetamine.
   99         40. 3,4-Methylenedioxymethcathinone.
  100         41. 3,4-Methylenedioxypyrovalerone (MDPV).
  101         42. Methylmethcathinone.
  102         43. Methoxymethcathinone.
  103         44. Fluoromethcathinone.
  104         45. Methylethcathinone.
  105         46. 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2
  106  yl)phenol, also known as CP 47,497 and its dimethyloctyl (C8)
  107  homologue.
  108         47. (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2
  109  methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol,
  110  also known as HU-210.
  111         48. 1-Pentyl-3-(1-naphthoyl)indole, also known as JWH-018.
  112         49. 1-Butyl-3-(1-naphthoyl)indole, also known as JWH-073.
  113         50. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl) indole, also
  114  known as JWH-200.
  115         51. BZP (Benzylpiperazine).
  116         52. Fluorophenylpiperazine.
  117         53. Methylphenylpiperazine.
  118         54. Chlorophenylpiperazine.
  119         55. Methoxyphenylpiperazine.
  120         56. DBZP (1,4-dibenzylpiperazine).
  121         57. TFMPP (3-Trifluoromethylphenylpiperazine).
  122         58. MBDB (Methylbenzodioxolylbutanamine).
  123         59. 5-Hydroxy-alpha-methyltryptamine.
  124         60. 5-Hydroxy-N-methyltryptamine.
  125         61. 5-Methoxy-N-methyl-N-isopropyltryptamine.
  126         62. 5-Methoxy-alpha-methyltryptamine.
  127         63. Methyltryptamine.
  128         64. 5-Methoxy-N,N-dimethyltryptamine.
  129         65. 5-Methyl-N,N-dimethyltryptamine.
  130         66. Tyramine (4-Hydroxyphenethylamine).
  131         67. 5-Methoxy-N,N-Diisopropyltryptamine.
  132         68. DiPT (N,N-Diisopropyltryptamine).
  133         69. DPT (N,N-Dipropyltryptamine).
  134         70. 4-Hydroxy-N,N-diisopropyltryptamine.
  135         71. N,N-Diallyl-5-Methoxytryptamine.
  136         72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
  137         73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
  138         74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  139         75. 2C-T-4 (2,5-Dimethoxy-4-isopropylthiophenethylamine).
  140         76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  141         77. 2C-T (2,5-Dimethoxy-4-methylthiophenethylamine).
  142         78. 2C-T-2 (2,5-Dimethoxy-4-ethylthiophenethylamine).
  143         79. 2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine).
  144         80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  145         81. Butylone (beta-keto-N-methylbenzodioxolylpropylamine).
  146         82. Ethcathinone.
  147         83. Ethylone (3,4-methylenedioxy-N-ethylcathinone).
  148         84. Naphyrone (naphthylpyrovalerone).
  149         85. N-N-Dimethyl-3,4-methylenedioxycathinone.
  150         86. N-N-Diethyl-3,4-methylenedioxycathinone.
  151         87. 3,4-methylenedioxy-propiophenone.
  152         88. 2-Bromo-3,4-Methylenedioxypropiophenone.
  153         89. 3,4-methylenedioxy-propiophenone-2-oxime.
  154         90. N-Acetyl-3,4-methylenedioxycathinone.
  155         91. N-Acetyl-N-Methyl-3,4-Methylenedioxycathinone.
  156         92. N-Acetyl-N-Ethyl-3,4-Methylenedioxycathinone.
  157         93. Bromomethcathinone.
  158         94. Buphedrone (alpha-methylamino-butyrophenone).
  159         95. Eutylone (beta-Keto-Ethylbenzodioxolylbutanamine).
  160         96. Dimethylcathinone.
  161         97. Dimethylmethcathinone.
  162         98. Pentylone (beta-Keto-Methylbenzodioxolylpentanamine).
  163         99. (MDPPP) 3,4-Methylenedioxy-alpha
  164  pyrrolidinopropiophenone.
  165         100. (MDPBP) 3,4-Methylenedioxy-alpha
  166  pyrrolidinobutiophenone.
  167         101. Methoxy-alpha-pyrrolidinopropiophenone (MOPPP).
  168         102. Methyl-alpha-pyrrolidinohexiophenone (MPHP).
  169         103. Benocyclidine (BCP) or
  170  benzothiophenylcyclohexylpiperidine (BTCP).
  171         104. Fluoromethylaminobutyrophenone (F-MABP).
  172         105. Methoxypyrrolidinobutyrophenone (MeO-PBP).
  173         106. Ethyl-pyrrolidinobutyrophenone (Et-PBP).
  174         107. 3-Methyl-4-Methoxymethcathinone (3-Me-4-MeO-MCAT).
  175         108. Methylethylaminobutyrophenone (Me-EABP).
  176         109. Methylamino-butyrophenone (MABP).
  177         110. Pyrrolidinopropiophenone (PPP).
  178         111. Pyrrolidinobutiophenone (PBP).
  179         112. Pyrrolidinovalerophenone (PVP).
  180         113. Methyl-alpha-pyrrolidinopropiophenone (MPPP).
  181         114. JWH-007 (1-pentyl-2-methyl-3-(1-naphthoyl)indole).
  182         115. JWH-015 (2-Methyl-1-propyl-1H-indol-3-yl)-1
  183  naphthalenylmethanone).
  184         116. JWH-019 (Naphthalen-1-yl-(1-hexylindol-3
  185  yl)methanone).
  186         117. JWH-020 (1-heptyl-3-(1-naphthoyl)indole).
  187         118. JWH-072 (Naphthalen-1-yl-(1-propyl-1H-indol-3
  188  yl)methanone).
  189         119. JWH-081 (4-methoxynaphthalen-1-yl-(1-pentylindol-3
  190  yl)methanone).
  191         120. JWH-122 (1-pentyl-3-(4-methyl-1-naphthoyl)indole).
  192         121. JWH-133 ((6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a
  193  tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran)).
  194         122. JWH-175 (3-(naphthalen-1-ylmethyl)-1-pentyl-1H
  195  indole).
  196         123. JWH-201 (1-pentyl-3-(4-methoxyphenylacetyl)indole).
  197         124. JWH-203 (2-(2-chlorophenyl)-1-(1-pentylindol-3
  198  yl)ethanone).
  199         125. JWH-210 (4-ethylnaphthalen-1-yl-(1-pentylindol-3
  200  yl)methanone).
  201         126. JWH-250 (2-(2-methoxyphenyl)-1-(1-pentylindol-3
  202  yl)ethanone).
  203         127. JWH-251 (2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3
  204  yl)ethanone).
  205         128. JWH-302 (1-pentyl-3-(3-methoxyphenylacetyl)indole).
  206         129. JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
  207         130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  208  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  209  ol).
  210         131. HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan
  211  2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
  212  methanol).
  213         132. HU-331 (3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-
  214  methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
  215  1,4-dione).
  216         133. CB-13 (Naphthalen-1-yl-(4-pentyloxynaphthalen-1
  217  yl)methanone).
  218         134. CB-25 (N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
  219  undecanamide).
  220         135. CB-52 (N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
  221  undecanamide).
  222         136. CP 55,940 (2-[(1R,2R,5R)-5-hydroxy-2-(3
  223  hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol).
  224         137. AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2
  225  iodophenyl)methanone).
  226         138. AM-2201 (1-[(5-fluoropentyl)-1H-indol-3-yl]
  227  (naphthalen-1-yl)methanone).
  228         139. RCS-4 ((4-methoxyphenyl) (1-pentyl-1H-indol-3
  229  yl)methanone).
  230         140. RCS-8 (1-(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2
  231  methoxyphenylethanone).
  232         141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
  233  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  234  naphthalenylmethanone).
  235         142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
  236  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  237  naphthalenylmethanone).
  238         143. Pentedrone (2-(methylamino)-1-phenyl-1-pentanone).
  239         144. Fluoroamphetamine.
  240         145. Fluoromethamphetamine.
  241         146. Methoxetamine.
  242         147. Methiopropamine.
  243         148. 4-Methylbuphedrone (2-Methylamino-1-(4
  244  methylphenyl)butan-1-one).
  245         149. APB ((2-aminopropyl)benzofuran).
  246         150. APDB ((2-aminopropyl)-2,3-dihydrobenzofuran).
  247         151. UR-144 ((1-pentyl-1H-indol-3-yl)(2,2,3,3
  248  tetramethylcyclopropyl)methanone).
  249         152. XLR11 ((1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3
  250  tetramethylcyclopropyl)methanone).
  251         153. (1-(5-chloropentyl)-1H-indol-3-yl)(2,2,3,3
  252  tetramethylcyclopropyl)methanone.
  253         154. AKB48 (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H
  254  indazole-3-carboxamide).
  255         155. AM-2233((2-iodophenyl)[1-[(1-methyl-2
  256  piperidinyl)methyl]-1H-indol-3-yl]-methanone).
  257         156. STS-135 (1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec
  258  1-yl-1H-indole-3-carboxamide).
  259         157. URB-597 ((3’-(aminocarbonyl)[1,1’-biphenyl]-3-yl)
  260  cyclohexylcarbamate).
  261         158. URB-602 ([1,1’-biphenyl]-3-yl-carbamic acid,
  262  cyclohexyl ester).
  263         159. URB-754 (6-methyl-2-[(4-methylphenyl)amino]-1
  264  benzoxazin-4-one).
  265         160. 2C-D (2-(2,5-Dimethoxy-4-methylphenyl)ethanamine).
  266         161. 2C-H (2-(2,5-Dimethoxyphenyl)ethanamine).
  267         162. 2C-N (2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine).
  268         163. 2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine).
  269         164. 25I-NBOMe (4-iodo-2,5-dimethoxy-N-[(2
  270  methoxyphenyl)methyl]-benzeneethanamine).
  271         165. 3,4-Methylenedioxymethamphetamine (MDMA).
  272         166. PB-22 (1-pentyl-8-quinolinyl ester-1H-indole-3
  273  carboxylic acid).
  274         167. 5-Fluoro PB-22 (8-quinolinyl ester-1-(5-fluoropentyl)
  275  1H-indole-3-carboxylic acid).
  276         168. BB-22 (1-(cyclohexylmethyl)-8-quinolinyl ester-1H
  277  indole-3-carboxylic acid).
  278         169. 5-Fluoro AKB48 (N-((3s,5s,7s)-adamantan-1-yl)-1-(5
  279  fluoropentyl)-1H-indazole-3-carboxamide).
  280         170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  281  pentyl-1H-indazole-3-carboxamide).
  282         171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  283  (4-fluorobenzyl)-1H-indazole-3-carboxamide).
  284         172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  285  1-pentyl-1H-indazole-3-carboxamide).
  286         173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  287  yl)-1-(fluoropentyl)-1H-indole-3-carboxamide).
  288         174. 25B-NBOMe (4-bromo-2,5-dimethoxy-N-[(2
  289  methoxyphenyl)methyl]-benzeneethanamine).
  290         175. 2C-C-NBOMe (4-chloro-2,5-dimethoxy-N-[(2
  291  methoxyphenyl)methyl]-benzeneethanamine).
  292         176. Kratom (Mitragyna speciosa).
  293         Section 2. Paragraphs (a) and (g) of subsection (30) of s.
  294  39.01, subsection (5) of s. 316.193, paragraph (c) of subsection
  295  (2) of s. 322.2616, subsection (5) of s. 327.35, paragraph (b)
  296  of subsection (11) of s. 440.102, paragraph (e) of subsection
  297  (1) of s. 458.3265, paragraph (e) of subsection (1) of s.
  298  459.0137, paragraph (a) of subsection (1) and subsection (4) of
  299  s. 782.04, paragraph (a) of subsection (2) of s. 787.06, s.
  300  817.563, paragraph (a) of subsection (1) and subsection (2) of
  301  s. 831.31, paragraph (c) of subsection (1) of s. 856.015,
  302  subsection (4) of s. 893.02, subsection (2), paragraph (a) of
  303  subsection (7), and paragraph (a) of subsection (8) of s.
  304  893.035, paragraph (a) of subsection (2) and subsection (5) of
  305  s. 893.0356, subsection (1) of s. 893.05, paragraphs (b), (c),
  306  and (d) of subsection (2) of s. 893.12, paragraphs (a), (c)
  307  through (f), and (h) of subsection (1), paragraph (a) of
  308  subsection (2), paragraph (b) of subsection (4), paragraph (b)
  309  of subsection (5), and paragraph (a) of subsection (7) of s.
  310  893.13, and paragraphs (b), (c), and (e) of subsection (3) of s.
  311  921.0022, Florida Statutes, are reenacted for the purpose of
  312  incorporating the amendment made by this act to s. 893.03,
  313  Florida Statutes, in references thereto.
  314         Section 3. This act shall take effect October 1, 2015.

Leave a Comment